Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Methenamine recalled?

Not under an active recall. Methenamine was recalled 12 times in the past — all now closed. Most recent: Jan 26, 2022.

Most common reason: Wrong potency / content (7 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Methenamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Methenamine recalls on record

none so far in 2026; 12 on record, newest first
Class II · Moderate risk

Cystex Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. D-0555-2022
Class II · Moderate risk

Vilamit Mb

cGMP deviations

Terminated cGMP deviation Vilvet Pharmaceuticals Inc. NDC 71186-002-35 D-1487-2020
Class II · Moderate risk

Urin D/S Tablets Methenamine 81.6 mg

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Terminated Wrong potency / content Llorens Pharmaceutical Corp. D-0081-2018
Class II · Moderate risk

Urolet Mb Urinary Antiseptic

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Terminated Wrong potency / content Burel Pharmaceuticals Inc NDC 35573-302-30 D-0156-2017
Class II · Moderate risk

Methenamine/Phenyl Salicylate Capsule

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1054-2015